Search Results - Michael D. Culler

Refine Results
  1. 1
    PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) POTENTIATES THE GONADOTROPIN-RELEASING ACTIVITY OF LUTEINIZING HORMONE-RELEASING HORMONE

    PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) POTENTIATES THE GONADOTROPIN-RELEASING ACTIVITY OF LUTEINIZING HORMONE-RELEASING HORMONE by Michael D. Culler, Carl S. Paschall

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Somatostatin Receptor-Specific Analogs: Effects on Cell Proliferation and Growth Hormone Secretion in Human Somatotroph Tumors<sup>1</sup>

    Somatostatin Receptor-Specific Analogs: Effects on Cell Proliferation and Growth Hormone Secretion in Human Somatotroph Tumors<sup>1</sup> by Daniel C. Danila, Jaafar N. Haidar, Xun Zhang, Laurence Katznelson, Michael D. Culler, Anne Klibanski

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.

    Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for func... by Ilan Shimon, Xiaoqian Yan, John E. Taylor, Martin H. Weiss, Michael D. Culler, Shlomo Melmed

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Functional Association of Somatostatin Receptor Subtypes 2 and 5 in Inhibiting Human Growth Hormone Secretion

    Functional Association of Somatostatin Receptor Subtypes 2 and 5 in Inhibiting Human Growth Hormone Secretion by Song-Guang Ren, John E. Taylor, Jesse Z. Dong, Run Yu, Michael D. Culler, Шломо Мелмед

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas

    Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas by Alessandra Fusco, Ginette Gunz, P Jaquet, Henry Dufour, Anne Laure Germanetti, Michael D. Culler, Anne Barlier, Alexandru Saveanu

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Demonstration of Enhanced Potency of a Chimeric Somatostatin-Dopamine Molecule, BIM-23A387, in Suppressing Growth Hormone and Prolactin Secretion from Human Pituitary Somatotroph Adenoma Cells

    Demonstration of Enhanced Potency of a Chimeric Somatostatin-Dopamine Molecule, BIM-23A387, in Suppressing Growth Hormone and Prolactin Secretion from Human Pituitary Somatotroph A... by Alexandru Saveanu, Esteban Lavaque, Ginette Gunz, Anne Barlier, S. Kim, John E. Taylor, Michael D. Culler, A Enjalbert, P Jaquet

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Suppression of Rat and Human Growth Hormone and Prolactin Secretion by a Novel Somatostatin/Dopaminergic Chimeric Ligand

    Suppression of Rat and Human Growth Hormone and Prolactin Secretion by a Novel Somatostatin/Dopaminergic Chimeric Ligand by Song-Guang Ren, Sun H. Kim, John E. Taylor, Josse Dong, Jacques-Pierre Moreau, Michael D. Culler, Шломо Мелмед

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease

    Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease by Rocco Barazzoni, Xinxia Zhu, Mark D. DeBoer, Rakesh Datta, Michael D. Culler, Michela Zanetti, Gianfranco Guarnieri, Daniel L. Marks

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Quantitative and Functional Expression of Somatostatin Receptor Subtypes in Human Prolactinomas<sup>1</sup>

    Quantitative and Functional Expression of Somatostatin Receptor Subtypes in Human Prolactinomas<sup>1</sup> by P Jaquet, L’Houcine Ouafik, Alexandru Saveanu, Ginette Gunz, F. Fina, Henry Dufour, Michael D. Culler, J. P. Moreau, A Enjalbert

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Endogenous Ghrelin Regulates Episodic Growth Hormone (GH) Secretion by Amplifying GH Pulse Amplitude: Evidence from Antagonism of the GH Secretagogue-R1a Receptor

    Endogenous Ghrelin Regulates Episodic Growth Hormone (GH) Secretion by Amplifying GH Pulse Amplitude: Evidence from Antagonism of the GH Secretagogue-R1a Receptor by Philippe Zizzari, Heather Halem, John E. Taylor, J. Z. Dong, Rakesh Datta, Michael D. Culler, Jacques Epelbaum, Marie‐Thérèse Bluet‐Pajot

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

    Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy by Anat Ben-Shlomo, Herbert Schmid, Kolja Wawrowsky, Oxana Pichurin, Erika Hubina, Vera Chesnokova, Ning‐Ai Liu, Michael D. Culler, Шломо Мелмед

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Taspoglutide, an Analog of Human Glucagon-Like Peptide-1 with Enhanced Stability and in Vivo Potency

    Taspoglutide, an Analog of Human Glucagon-Like Peptide-1 with Enhanced Stability and in Vivo Potency by E Seböková, Andreas D. Christ, Haiyan Wang, Sabine Sewing, Jesse Z. Dong, John E. Taylor, Michael A. Cawthorne, Michael D. Culler

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Effect of ghrelin and its analogues, BIM‐28131 and BIM‐28125, on the expression of myostatin in a rat heart failure model

    Effect of ghrelin and its analogues, BIM‐28131 and BIM‐28125, on the expression of myostatin in a rat heart failure model by Karsten Lenk, Sandra Palus, Robert Schur, Rakesh Datta, Jesse Z. Dong, Michael D. Culler, Stefan D. Anker, Jochen Springer, Gerhard Schüler, Volker Adams

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    BIM-23244, a Somatostatin Receptor Subtype 2- and 5-Selective Analog with Enhanced Efficacy in Suppressing Growth Hormone (GH) from Octreotide-Resistant Human GH-Secreting Adenomas1

    BIM-23244, a Somatostatin Receptor Subtype 2- and 5-Selective Analog with Enhanced Efficacy in Suppressing Growth Hormone (GH) from Octreotide-Resistant Human GH-Secreting Adenomas... by Alexandru Saveanu, Ginette Gunz, Henry Dufour, P. Caron, F. Fina, L’Houcine Ouafik, Michael D. Culler, J. P. Moreau, A Enjalbert, P Jaquet

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.

    Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin reg... by Ilan Shimon, John E. Taylor, J. Z. Dong, R A Bitonte, S. Kim, B.A. Morgan, D.H. Coy, Michael D. Culler, Шломо Мелмед

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Somatostatin Receptor Subtype 1 Selective Activation in Human Growth Hormone (GH)- and Prolactin (PRL)-Secreting Pituitary Adenomas: Effects on Cell Viability, GH, and PRL Secretion

    Somatostatin Receptor Subtype 1 Selective Activation in Human Growth Hormone (GH)- and Prolactin (PRL)-Secreting Pituitary Adenomas: Effects on Cell Viability, GH, and PRL Secretio... by Maria Chiara Zatelli, Daniela Piccin, Federico Tagliati, Maria Rosaria Ambrosio, Angelo Margutti, Roberto Padovani, M. Scanarini, Michael D. Culler, Ettore C. degli Uberti

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy

    Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classi... by P Jaquet, Ginette Gunz, Alexandru Saveanu, H. Dufour, John E. Taylor, Jesse Z. Dong, S. Kim, J. P. Moreau, A Enjalbert, Michael D. Culler

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Somatostatin Inhibits Tumor Angiogenesis and Growth via Somatostatin Receptor-3-Mediated Regulation of Endothelial Nitric Oxide Synthase and Mitogen-Activated Protein Kinase Activities

    Somatostatin Inhibits Tumor Angiogenesis and Growth via Somatostatin Receptor-3-Mediated Regulation of Endothelial Nitric Oxide Synthase and Mitogen-Activated Protein Kinase Activi... by Tullio Florio, Monica Morini, Valentina Villa, Sara Arena, Alessandro Corsaro, Stefano Thellung, Michael D. Culler, Ulrich Pfeffer, Douglas M. Noonan, Gennaro Schettini, Adriana Albini

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Adropin Deficiency Is Associated With Increased Adiposity and Insulin Resistance

    Adropin Deficiency Is Associated With Increased Adiposity and Insulin Resistance by K. Ganesh‐Kumar, Jingying Zhang, Su Gao, Jari Rossi, Owen P. McGuinness, Heather H. Halem, Michael D. Culler, Randall L. Mynatt, Andrew A. Butler

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice

    Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice by K. Ganesh Kumar, Gregory M. Sutton, Jesse Z. Dong, Pierre Roubert, Pascale Plas, Heather Halem, Michael D. Culler, Hyunwon Yang, Vishwa Deep Dixit, Andrew A. Butler

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: